Metastases with CUP syndrome;Metastasen mit unbekanntem primärtumor (CUP)

Urologe - Ausgabe A

Volumn 45, Issue 5, 2006, Pages 614-619

  Seeber, S ^a   Strumberg, D ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

CUP syndrome; Immunohistology; Metastasis; PET; Unknown origin

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; INTERFERON; NAVELBINE; OCTREOTIDE; OXALIPLATIN; PACLITAXEL; TAXANE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CARCINOMA OF UNKNOWN PRIMARY SYNDROME; CARCINOMATOUS PERITONITIS; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNE SYSTEM; IMMUNOHISTOLOGY; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM; METASTASIS; NEOPLASM; OVARY CARCINOMA; PROGNOSIS; QUALITY OF LIFE; RETROPERITONEUM; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, UNKNOWN PRIMARY; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; SYNDROME; TERMINAL CARE; UROGENITAL NEOPLASMS;

EID: 33646888224     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-006-1054-2     Document Type: Article

References (40)

1. Abbruzzese JL, Abbruzzese MC, Hess KR et al. (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12(6): 1272-1280
2. Abbruzzese JL, Abbruzzese MC, Lenzi R et al. (1995) Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13(8): 2094-20103
3. Alizadeh AA, Ross DT, Perou CM, van de Rijn M (2001) Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195(1): 41-52
4. Altman E, Cadman E (1986) An analysis of 1539 patients with cancer of unknown primary site. Cancer 57(1): 120-124
5. Argiris A, Smith SM, Stenson K et al. (2003) Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 14(8): 1306-1311
6. Bar-Eli M, Abbruzzese JL, Lee-Jackson D, Frost P (1993) p53 gene mutation spectrum in human unknown primary tumors. Anticancer Res 13(5A): 1619-1623
7. Baron PL, Moore MP, Kinne DW et al. (1990) Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 125(2): 210-214
8. Bataini JP, Rodriguez J, Jaulerry C et al. (1987) Treatment of metastatic neck nodes secondary to an occult epidermoid carcinoma of the head and neck. Laryngoscope 97(9): 1080-1084
9. Bell CW, Pathak S, Frost P (1989) Unknown primary tumors: establishment of cell lines, identification of chromosomal abnormalities, and implications for a second type of tumor progression. Cancer Res 49(15): 4311-4315
10. Bernier J, Domenge C, Ozsahin M et al. (2004) Post-operative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19): 1945-1952
11. Bohuslavizki KH, Klutmann S, Kroger S et al. (2000) FDG PET detection of unknown primary tumors. J Nucl Med 41(5): 816-822
12. Briasoulis E, Kalofonos H, Bafaloukos D et al. (2000) Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol 18(17): 3101-3107
13. Cooper JS, Pajak TF, Forastiere AA et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19): 1937-1944
14. Culine S, Kramar A, Saghatchian M et al. (2002) Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 20(24): 4679-4683
15. De Braud F, al-Sarraf M (1993) Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 20(3): 273-278
16. DeYoung BR, Wick MR (2000) Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach. Semin Diagn Pathol 17(3): 184-193
17. Foroudi F, Tiver KW (2000) Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys 47(1): 143-147
18. Grau C, Johansen LV, Jakobsen J et al. (2001) Cervical lymphatic metastases from occult primary tumor. A nation-wide 20-year study from the Danish society of head and neck oncology. Ugeskr Laeger 163(10): 1432-1436
19. Hainsworth JD, Johnson DH, Greco FA (1992) Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience. J Clin Oncol 10(6): 912-922
20. Hess KR, Abbruzzese MC, Lenzi R et al. (1999) Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 5(11): 3403-3410
21. Hogan BA, Thornton FJ, Brannigan M et al. (2002) Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations. Clin Radiol 57(12): 1073-1077
22. Kaufmann O, Fietze E, Dietel M (2002) Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor. Pathologe 23(3): 183-197
23. Keith WN (2004) From stem cells to cancer: balancing immortality and neoplasia. Oncogene 23(29): 5092-5094
24. Kole AC, Nieweg OE, Pruim J et al. (1998) Detection of unknown occult primary tumors using positron emission tomography. Cancer 82(6): 1160-1166
25. Lamerz R (1989) Clinical relevance of tumor markers. Wien Klin Wochenschr 101(14): 464-472
26. Le Chevalier T, Cvitkovic E, Caille P et al. (1988) Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 148(9): 2035-2039
27. Lenzi R, Hess KR, Abbruzzese MC et al. (1997) Poorly differentiated carcinoma an dpoorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma? J Clin Oncol 5: 2056-2066
28. Lortholary A, Abadie-Lacourtoisie S, Guerin O et al. (2001) Cancers of unknown origin: 311 cases. Bull Cancer 88(6): 619-627
29. Mackay B, Ordonez NG (1993) Pathological evaluation of neoplasms with unknown primary tumor site. Semin Oncol 20(3): 206-228
30. Mantaka P, Baum RP, Hertel A et al. (2003) PET with 2-[F-18]-fluoro-2- deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management. Cancer Biother Radiopharm 18(1): 47-58
31. Milovic M, Popov I, Jelic S (2002) Tumor markers in metastatic disease from cancer of unknown primary origin. Med Sci Monit 8(2): 25-30
32. Namba N, Hiraki A, Tabata M et al. (2002) Axillary metastasis as the first manifestation of occult breast cancer in a man: a case report. Anticancer Res 22(6B): 3611-3613
33. Rades D, Kuhnel G, Wildfang I et al. (2001) Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 12(11): 1605-1609
34. Saad ED, Abbruzzese JL (2002) Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinoma. Crit Rev Oncol Hematol 41(2): 205-211
35. Trosko JE (2003) The role of stem cells and gap junctional intercellular communication in carcinogenesis. J Biochem Mol Biol 36(1): 43-48
36. van der Gaast A, Verweij J, Planting AS et al. (1995) Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site. J Clin Oncol 13(7): 1720-1725
37. van de Wouw AJ, Jansen RL, Speel EJ, Hillen HF (2003) The unknown biology of the unknown primary tumour: a literature review. Ann Oncol 14(2): 191-196
38. Vlastos G, Jean ME, Mirza AN et al. (2001) Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8(5): 425-431
39. Weber A, Schmoz S, Bootz F (2001) CUP (carcinoma of unknown primary) syndrome in head and neck: clinic, diagnostic, and therapy. Onkologie 24(1): 38-43
40. Zuur CL, van Velthuysen ML, Schornagel JH et al. (2002) Diagnosis and treatment of isolated neck metastases of adenocarcinomas. Eur J Surg Oncol 28(2): 147-152